IB TIB 140mg Capsule

IB TIB 140mg Capsule contains the active ingredient Ibrutinib. It is indicated for the treatment of haematological malignancies including mantle cell lymphoma (MCL), chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL), Waldenström macroglobulinaemia, and marginal zone lymphoma (MZL). These are malignancies of lymphocytes, the white blood cells that form part of the immune system. They are distinguished by the anatomical site of malignancy, the lymphocyte subtype involved, and other clinical features. IB TIB 140mg Capsule is also used in the treatment of chronic graft versus host disease (cGvHD) following failure of systemic therapy. During allogeneic stem cell transplantation, stem cells from a donor are administered to the patient. GvHD occurs when donor cells recognise the patient's cells as foreign and mount an immune response against them.

Before commencing IB TIB 140mg Capsule, inform your physician if you have bleeding disorders, active infection, hepatic impairment, cardiac disease, or intolerance to certain sugars. This medication is not recommended for paediatric patients and adolescents. Inform your physician if you have recently undergone or are scheduled for any surgical procedure. Your physician may discontinue IB TIB 140mg Capsule in advance of planned surgical or medical interventions. Use effective contraception during treatment and for at least one month following the final dose. Avoid consumption of grapefruit or oranges in any form during treatment as these may increase blood concentrations of the medication. Maintain adequate fluid intake to prevent dehydration. Notify your physician if diarrhoea develops and persists.

Ib Tib 140mg Capsule is used in the treatment of Mantle cell lymphoma Chronic lymphocytic leukemia (Blood cancer) Small lymphocytic lymphoma Waldenstrom’s macroglobulinemia Chronic graft vs. host disease after failure of systemic therapy

The mechanism of action of Ib Tib 140mg involves blocking a specific protein called Bruton's tyrosine kinase (BTK) which plays a key role in the survival and growth of cancer cells. By inhibiting BTK, Ib Tib 140mg prevents the cancer cells from receiving the signals they need to grow and divide, leading to their eventual death.

Consume this medicine at the same time each day. While taking Ib Tib 140mg do not consume grapefruit or orange in any form during the treatment. Drink plenty of fluid to prevent dehydration.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Bleeding problems Infections Decrease in blood cell counts Heart problems High BP Secondary cancer Tumor lysis syndrome Severe allergic reactions Common Nausea, vomiting, diarrhea Tiredness Muscle and bone pain Rash and bruising Mouth sores Pneumonia Fever, chills Breathlessness Constipation Dizziness Body pain Swollen ankles and feet Increased creatinine levels in blood Heavier periods and blood in urine Blurred vision Weakness and numbness

Contact your doctor immediately if you experience bleeding, infection, shortness of breath, or chest discomfort. Report to your doctor if you have had a history of heart failure or hepatitis infection. It is not recommended to take this medicine before or after surgery as it causes a delay in wound healing. Discuss effective contraceptive options with your healthcare provider and use them during treatment and for a month after the last dose of Ib Tib 140mg .